Ajanta Pharma shares rose 13.5% to an all-time high on record Q1 earnings and a new buyback plan.
Ajanta Pharma shares soared 13.5% to a new all-time high of ₹2,540 following the company's significant March quarter earnings and its buyback plans. The company's board approved its fourth buyback plan in four years, repurchasing up to 10.28 lakh equity shares, amounting to 0.82% of the total outstanding shares. Ajanta Pharma recorded a 66% increase in consolidated net profit to ₹202.72 crore for the January-March period.
May 02, 2024
9 Articles